TipRanks
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
US Market
CTXR
Citius Pharmaceuticals
RESEARCH TOOLSreports
Want to see CTXR full AI Analyst Report?

Citius Pharmaceuticals (CTXR) Income Statement

1,810 Followers

Citius Pharmaceuticals Income Statement

Last quarter (Q3 2026), Citius Pharmaceuticals's total revenue was $1.49M, an increase of Infinity% from the same quarter last year. In Q3, Citius Pharmaceuticals's net income was $-8.86M. See Citius Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Dec 23Sep 22Sep 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -214.25K$ -209.61K$ 0.00$ 0.00$ -164.87K
Operating Expenses
$ 38.31M$ 42.00M$ 36.73M$ 33.32M$ 23.37M
Depreciation and Amortization
$ 214.25K$ 209.61K$ 194.32K$ 179.68K$ 164.87K
EBITDA
$ -38.20M$ -38.64M$ -36.54M$ -33.14M$ -23.37M
Operating Income
$ -38.53M$ -42.00M$ -36.73M$ -33.32M$ -23.53M
Other Income/Expenses
$ -157.70K$ 3.15M$ 4.77M$ 251.40K$ 477.46K
Pretax Income
$ -38.68M$ -38.85M$ -31.97M$ -33.06M$ -23.05M
Net Income
$ -37.43M$ -39.14M$ -32.54M$ -33.64M$ -23.05M
Per Share Metrics
Basic EPS
$ -3.38$ -5.97$ -5.57$ -5.75$ -5.64
Diluted EPS
$ -3.38$ -5.97$ -5.57$ -5.75$ -5.64
Weighted Average Shares Outstanding
 11.07M 11.59M 6.05M 5.84M 4.34M
Weighted Average Shares Outstanding (Diluted)
 11.07M 11.59M 6.05M 5.84M 4.34M
Currency in USD

Citius Pharmaceuticals Earnings and Revenue History